ID   LPDA_MYCTU              Reviewed;         493 AA.
AC   P9WHH7; L0TC51; O53355; Q8VJ36;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   07-APR-2021, entry version 45.
DE   RecName: Full=NAD(P)H dehydrogenase (quinone);
DE            EC=1.6.5.2;
DE   AltName: Full=NAD(P)H quinone reductase;
DE   AltName: Full=NAD(P)H: menadione oxidoreductase;
DE   AltName: Full=NADH-menadione reductase;
GN   Name=lpdA; Synonyms=lpdA-2; OrderedLocusNames=Rv3303c;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17097323; DOI=10.1016/j.micinf.2006.09.004;
RA   Akhtar P., Srivastava S., Srivastava A., Srivastava M., Srivastava B.S.,
RA   Srivastava R.;
RT   "Rv3303c of Mycobacterium tuberculosis protects tubercle bacilli against
RT   oxidative stress in vivo and contributes to virulence in mice.";
RL   Microbes Infect. 8:2855-2862(2006).
RN   [3]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) IN COMPLEX WITH FAD, MASS
RP   SPECTROMETRY, FUNCTION, SUBUNIT, SUBSTRATE SPECIFICITY, REACTION MECHANISM,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15456792; DOI=10.1074/jbc.m410704200;
RA   Argyrou A., Vetting M.W., Blanchard J.S.;
RT   "Characterization of a new member of the flavoprotein disulfide reductase
RT   family of enzymes from Mycobacterium tuberculosis.";
RL   J. Biol. Chem. 279:52694-52702(2004).
CC   -!- FUNCTION: May contribute to virulence by increasing resistance to
CC       reactive oxygen intermediates. It can reduce 2,6-dimethyl-1,4-
CC       benzoquinone (DMBQ), 5-hydroxy-1,4-naphthaquinone (5-HNQ) and
CC       menadione. NADPH is the physiological reductant rather than NADH.
CC       {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.39 uM for 5-HNQ (with NADPH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=0.44 uM for NADPH (with 5-HNQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=0.53 uM for NADPH (with DMBQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=1.6 uM for DMBQ (with NADPH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=5.4 uM for oxidized thionicotinamide adenine dinucleotide
CC         (thio_NAD)(with NADH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=5.5 uM for 5-HNQ (with NADH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=11 uM for DMBQ (with NADH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=18 uM for oxidized thionicotinamide adenine dinucleotide
CC         (thio_NAD)(with NADPH at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=28 uM for NADH (with 5-HNQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         KM=35.7 uM for menadione (at pH 7.5) {ECO:0000269|PubMed:15456792,
CC         ECO:0000269|PubMed:17097323};
CC         KM=36 uM for NADH (with DMBQ at pH 7.5 and at 25 degrees Celsius)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC         Vmax=20 umol/min/mg enzyme with menadione (at pH 7.5)
CC         {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15456792}.
CC   -!- MASS SPECTROMETRY: Mass=52543; Mass_error=3; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:15456792};
CC   -!- MISCELLANEOUS: Catalysis proceeds by a classical ping-pong bi-bi
CC       reaction mechanism.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- CAUTION: Despite significant sequence similarity to lipoamide
CC       dehydrogenases this protein cannot catalyze the reduction of lipoyl
CC       substrates. It lacks one of two cysteine residues involved in dithiol-
CC       disulfide interchange with lipoyl substrates and a His-Glu pair
CC       involved in general acid catalysis. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP46122.1; -; Genomic_DNA.
DR   PIR; F70841; F70841.
DR   RefSeq; NP_217820.1; NC_000962.3.
DR   RefSeq; WP_009936266.1; NZ_NVQJ01000003.1.
DR   PDB; 1XDI; X-ray; 2.81 A; A/B=1-493.
DR   PDBsum; 1XDI; -.
DR   SMR; P9WHH7; -.
DR   STRING; 83332.Rv3303c; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   PaxDb; P9WHH7; -.
DR   GeneID; 887659; -.
DR   KEGG; mtu:Rv3303c; -.
DR   TubercuList; Rv3303c; -.
DR   eggNOG; COG1249; Bacteria.
DR   OMA; SHCLMAV; -.
DR   PhylomeDB; P9WHH7; -.
DR   SABIO-RK; P9WHH7; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:MTBBASE.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:MTBBASE.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0070401; F:NADP+ binding; IDA:MTBBASE.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:MTBBASE.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0009405; P:pathogenesis; IMP:MTBBASE.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
PE   1: Evidence at protein level;
KW   3D-structure; FAD; Flavoprotein; NAD; Oxidoreductase; Reference proteome.
FT   CHAIN           1..493
FT                   /note="NAD(P)H dehydrogenase (quinone)"
FT                   /id="PRO_0000391461"
FT   NP_BIND         12..13
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   NP_BIND         35..37
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   NP_BIND         42..43
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   NP_BIND         324..325
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         52
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         117
FT                   /note="FAD; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         317
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   BINDING         450
FT                   /note="FAD; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:15456792"
FT   STRAND          3..8
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           12..24
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   TURN            26..28
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          29..37
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           41..45
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           48..64
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   TURN            65..71
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           83..107
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          111..119
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          122..124
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          127..134
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          140..150
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          154..156
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           160..162
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          166..171
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           172..177
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          183..189
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           192..203
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          208..211
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          213..218
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           223..235
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          239..241
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          246..251
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          253..260
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          265..273
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          277..279
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          282..284
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   TURN            286..290
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   TURN            295..297
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          303..306
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          312..314
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           317..319
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           325..339
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           349..351
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          353..356
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          358..367
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           369..373
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          379..386
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           390..394
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          401..407
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   TURN            408..410
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          412..420
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           423..436
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           440..444
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   STRAND          450..452
FT                   /evidence="ECO:0007744|PDB:1XDI"
FT   HELIX           454..464
FT                   /evidence="ECO:0007744|PDB:1XDI"
SQ   SEQUENCE   493 AA;  51489 MW;  71C3F1483665278C CRC64;
     MVTRIVILGG GPAGYEAALV AATSHPETTQ VTVIDCDGIG GAAVLDDCVP SKTFIASTGL
     RTELRRAPHL GFHIDFDDAK ISLPQIHARV KTLAAAQSAD ITAQLLSMGV QVIAGRGELI
     DSTPGLARHR IKATAADGST SEHEADVVLV ATGASPRILP SAQPDGERIL TWRQLYDLDA
     LPDHLIVVGS GVTGAEFVDA YTELGVPVTV VASQDHVLPY EDADAALVLE ESFAERGVRL
     FKNARAASVT RTGAGVLVTM TDGRTVEGSH ALMTIGSVPN TSGLGLERVG IQLGRGNYLT
     VDRVSRTLAT GIYAAGDCTG LLPLASVAAM QGRIAMYHAL GEGVSPIRLR TVAATVFTRP
     EIAAVGVPQS VIDAGSVAAR TIMLPLRTNA RAKMSEMRHG FVKIFCRRST GVVIGGVVVA
     PIASELILPI AVAVQNRITV NELAQTLAVY PSLSGSITEA ARRLMAHDDL DCTAAQDAAE
     QLALVPHHLP TSN
//
